Addition of short-term androgen deprivation therapy to dose-escalated radiation therapy improves failure-free survival for select men with intermediate-risk prostate cancer
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/23/9/2346/975257/mds001.pdf
Reference23 articles.
1. Long-term failure patterns and survival in a randomized dose-escalation trial for prostate cancer. Who dies of disease?;Kuban;Int J Radiat Oncol Biol Phys,2011
2. Prostate biopsy status and PSA nadir level as early surrogates for treatment failure: analysis of a prostate cancer randomized radiation dose escalation trial;Pollack;Int J Radiat Oncol Biol Phys,2002
3. Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy;Peeters;J Clin Oncol,2006
4. Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial;Zietman;JAMA,2005
5. Radiotherapy and short-term androgen deprivation for localized prostate cancer;Jones;N Engl J Med,2011
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Revolutionizing localized prostate cancer treatment: Stereotactic radiotherapy “Moroccan experience”;Archivio Italiano di Urologia e Andrologia;2024-02-16
2. Prostate Cancer;Oncologic Imaging : a Multidisciplinary Approach;2023
3. Androgen Deprivation Therapy for Prostate Cancer Did Not Increase the Risk of Retinal Vascular Occlusion: A Population-Based Cohort Study;International Journal of Environmental Research and Public Health;2022-02-17
4. Acute toxicity of 4-week versus 5-week hypofractionated radiotherapy in localised prostate cancer;Journal of Radiotherapy in Practice;2021-04-14
5. Dose–response with stereotactic body radiotherapy for prostate cancer: A multi-institutional analysis of prostate-specific antigen kinetics and biochemical control;Radiotherapy and Oncology;2021-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3